Close
4

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Company profile for Orsenix

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers. Our investigational ATO, ORH-2014, is a patented, oral capsule that achieved the required target exposure at a dose of 15 mg once daily in a recently completed Phase 1 Study. ORH-2014 has been granted Orphan Drug Designation by both FDA and EMEA, and Orsenix gained a...
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers. Our investigational ATO, ORH-2014, is a patented, oral capsule that achieved the required target exposure at a dose of 15 mg once daily in a recently completed Phase 1 Study. ORH-2014 has been granted Orphan Drug Designation by both FDA and EMEA, and Orsenix gained alignment with the FDA to proceed with a single registrational study for accelerated approval of ORH-2014 for the treatment of newly diagnosed patients with APL, assuming favorable regulatory review.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Orsenix
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1105 N. Market Street, Suite 1800, Wilmington, Delaware 19807
Telephone
Telephone
302-510-8961
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY